Plague
Scientists at University of Kentucky, Department of Pharmaceutical Sciences target plague
Published in TB and Outbreaks Week, February 20th, 2007
Research findings, "Investigating the geminal diamine intermediate of Yersinia pestis arginine decarboxylase with substrate, product, and inhibitors using single wavelength stopped-flow spectroscopy," are discussed in a new report. According to a study from the United States, "The reaction mechanism of Yersinia pestis arginine decarboxylase has been investigated using a series of substrate, product, and inhibitors. Using single wavelength stopped-flow spectroscopy, novel mechanistic features were noted in the presence of the product, agmatine."
"By focusing on the excitation and emission wavelengths of the geminal diamine intermediate, we were able to monitor the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Leishmaniasis
U.S. FDA grants VioQuest, U.S. Army orphan drug status for cutaneous leishmaniasis therapy - Thrombocytopenic Purpura
New thrombocytopenic purpura study findings reported from Kitasato University - Tuberculosis
New tuberculosis research reported from Catholic University, Pharmacy Department - Tuberculosis
Research from Chang Gung Memorial Hospital, Department of Internal Medicine has provided new information about tuberculosis - Tuberculosis
Research from Menssana Research Inc. reveals new findings on tuberculosis - Tuberculosis
Research from Saint-Joseph University, Department of Gastroenterology yields new data on tuberculosis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
